For companies in the Ozempic-fueled weight-loss economy, it's survival of the fittest

  • 📰 latimes
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 82%

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen

As powerful anti-obesity drugs become more widely available, companies are repositioning themselves with new products and services.

Before he began taking Mounjaro last summer, Nick Lovell was the weight-loss economy's ideal customer. He signed up for WeightWatchers and bought 'Dr. Atkins' Diet Revolution' to try the low-carb regimen. He joined his first gym in middle school and has belonged to half a dozen others since. He paid for personal trainers and boutique fitness classes and underwent bariatric surgery in 2008. And yet, his 5-foot-9-inch frame stubbornly held onto its 258 pounds.

We’re actually thrilled at what lies ahead.” With many GLP-1 users reporting muscle loss as a side effect, Atkins is pushing its line of high-protein bars and shakes, “a deliciously easy way to meet your protein requirements to help you maintain lean muscle mass and bone health while you’re losing weight.

 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 11. in DE

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen